- Expression of multidrug transporter MRP4/ABCC4 is a marker of poor prognosis in neuroblastoma and confers resistance to irinotecan in vitro. Norris, M.D., Smith, J., Tanabe, K., Tobin, P., Flemming, C., Scheffer, G.L., Wielinga, P., Cohn, S.L., London, W.B., Marshall, G.M., Allen, J.D., Haber, M. Mol. Cancer Ther. (2005)